Your browser doesn't support javascript.
loading
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
Vienot, Angélique; Jacquin, Marion; Rebucci-Peixoto, Magali; Pureur, Dimitri; Ghiringhelli, François; Assenat, Eric; Hammel, Pascal; Rosmorduc, Olivier; Stouvenot, Morgane; Allaire, Manon; Bouattour, Mohamed; Regnault, Hélène; Fratte, Serge; Raymond, Eric; Soularue, Emilie; Husson-Wetzel, Stéphanie; Di Martino, Vincent; Muller, Allison; Clairet, Anne-Laure; Fagnoni-Legat, Christine; Adotevi, Olivier; Meurisse, Aurélia; Vernerey, Dewi; Borg, Christophe.
Afiliação
  • Vienot A; Department of Medical Oncology, University Hospital of Besançon, 25000, Besançon, France. a3vienot@chu-besancon.fr.
  • Jacquin M; Clinical Investigational Center, CIC-1431, Besançon, France. a3vienot@chu-besancon.fr.
  • Rebucci-Peixoto M; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire Et Génique, Besançon, France. a3vienot@chu-besancon.fr.
  • Pureur D; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France. a3vienot@chu-besancon.fr.
  • Ghiringhelli F; Department of Medical Oncology, University Hospital of Besançon, 25000, Besançon, France.
  • Assenat E; Clinical Investigational Center, CIC-1431, Besançon, France.
  • Hammel P; Department of Medical Oncology, University Hospital of Besançon, 25000, Besançon, France.
  • Rosmorduc O; Clinical Investigational Center, CIC-1431, Besançon, France.
  • Stouvenot M; Department of Medical Oncology, University Hospital of Besançon, 25000, Besançon, France.
  • Allaire M; Department of Hepatology, University Hospital of Besançon, Besançon, France.
  • Bouattour M; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France.
  • Regnault H; Department of Medical Oncology, Saint Eloi Hospital, University Hospital, Montpellier of Montpellier, France.
  • Fratte S; Department of Digestive and Medical Oncology, Paul-Brousse Hospital, Villejuif, France.
  • Raymond E; Department of Hepato-Biliary, Paul-Brousse Hospital, Villejuif, France.
  • Soularue E; Department of Medical Oncology, University Hospital of Besançon, 25000, Besançon, France.
  • Husson-Wetzel S; Department of Gastroenterology, University Hospital of Besançon, Besançon, France.
  • Di Martino V; Department of Hepatogastroenterology, Pitié Salpêtrière Hospital, Paris, France.
  • Muller A; Department of Liver Cancer, Beaujon Hospital, Clichy, France.
  • Clairet AL; Department of Gastroenterology and Hepatology, Henri Mondor Hospital, Creteil, France.
  • Fagnoni-Legat C; Department of Gastroenterology, Nord Franche Comté Hospital, Montbéliard, France.
  • Adotevi O; Department of Medical Oncology, Paris Saint-Joseph Hospital, Paris, France.
  • Meurisse A; Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France.
  • Vernerey D; Department of Gastroenterology, Groupe Hospitalier de La Région Mulhouse Sud Alsace, Mulhouse, France.
  • Borg C; Department of Hepatology, University Hospital of Besançon, Besançon, France.
BMC Cancer ; 23(1): 710, 2023 Jul 29.
Article em En | MEDLINE | ID: mdl-37516867
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Telomerase / Vacinas Anticâncer / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Telomerase / Vacinas Anticâncer / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article